XML 52 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based compensation (Tables)
12 Months Ended
Mar. 31, 2021
Stock-based Compensation  
Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

Weighted

    

Weighted Average

    

 

 

 

Number of

 

Average

 

Contractual Term

 

Aggregate

 

 

Shares

 

Exercise Price

 

(Years)

 

Intrinsic Value

Outstanding as of March 31, 2020

 

4,964,381

 

$

9.78

 

8.03

 

$

15,345

Granted

 

2,622,519

 

 

18.10

 

9.22

 

 

 

Exercised

 

(794,477)

 

 

7.23

 

6.41

 

$

24,859

Cancelled

 

(332,239)

 

 

14.00

 

 

 

 

 

Outstanding as of March 31, 2021

 

6,460,184

 

 

13.26

 

7.95

 

$

116,193

Options exercisable as of March 31, 2020

 

2,117,721

 

$

5.67

 

7.20

 

$

11,733

Options exercisable as of March 31, 2021

 

2,698,708

 

$

8.38

 

6.79

 

$

59,717

 

Schedule of stock-based compensation expense

The following table summarizes the classification of stock-based compensation expense in the consolidated statements of operations for the years ended March 31, 2021 and 2020 as follows:

 

 

 

 

 

 

 

 

 

Twelve Months Ended

 

 

March 31,

 

    

2021

    

2020

Research and development

 

$

5,749

 

$

3,689

General and administrative

 

 

6,041

 

 

4,052

 

 

$

11,790

 

$

7,741

 

The following table summarizes stock-based compensation expense by award type for the years ended March 31, 2021 and 2020 as follows:

 

 

 

 

 

 

 

 

 

Twelve Months Ended

 

 

March 31,

 

    

2021

    

2020

Stock options

 

$

11,778

 

$

7,741

Restricted stock units

 

 

12

 

 

 —

 

 

$

11,790

 

$

7,741

 

Summary of changes in company's RSU

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Number of

 

Average

 

    

Restricted

    

Grant Date

 

    

Shares

    

Fair Value

Outstanding as of March 31, 2020

 

 —

 

$

 —

Granted

 

15,975

 

 

34.15

Vested

 

 —

 

 

 —

Cancelled

 

 —

 

 

 —

Outstanding as of March 31, 2021

 

15,975

 

 

34.15

 

Stock options  
Stock-based Compensation  
Schedule of assumptions used to determine the grant-date fair value of stock options granted

 

 

 

 

 

 

 

    

Twelve Months Ended

 

 

 

March 31, 

 

 

 

2021

    

2020

 

Risk-free interest rate

 

0.93

%  

2.12

%

Expected term (in years)

 

6.3

  

6.0

 

Expected volatility

 

75.4

%  

71.4

%

Expected dividend yield

 

 0

%  

 0

%